Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Med ; 9(10)2020 Oct 20.
Article in English | MEDLINE | ID: mdl-33092047

ABSTRACT

The use of additive manufacturing in dentistry has exponentially increased with dental model construction being the most common use of the technology. Henceforth, identifying the accuracy of additively manufactured dental models is critical. The objective of this study was to systematically review the literature and evaluate the accuracy of full-arch dental models manufactured using different 3D printing technologies. Seven databases were searched, and 2209 articles initially identified of which twenty-eight studies fulfilling the inclusion criteria were analysed. A meta-analysis was not possible due to unclear reporting and heterogeneity of studies. Stereolithography (SLA) was the most investigated technology, followed by digital light processing (DLP). Accuracy of 3D printed models varied widely between <100 to >500 µm with the majority of models deemed of clinically acceptable accuracy. The smallest (3.3 µm) and largest (579 µm) mean errors were produced by SLA printers. For DLP, majority of investigated printers (n = 6/8) produced models with <100 µm accuracy. Manufacturing parameters, including layer thickness, base design, postprocessing and storage, significantly influenced the model's accuracy. Majority of studies supported the use of 3D printed dental models. Nonetheless, models deemed clinically acceptable for orthodontic purposes may not necessarily be acceptable for the prosthodontic workflow or applications requiring high accuracy.

2.
Curr Cancer Drug Targets ; 19(8): 631-640, 2019.
Article in English | MEDLINE | ID: mdl-30387395

ABSTRACT

BACKGROUND: Co-culture of cancer cells with alveolar bone cells could modulate bone invasion and destructions. However, the mechanisms of interaction between oral squamous cell carcinoma (OSCC) and bone cells remain unclear. OBJECTIVE: The aim of this study is to analyse the direct and indirect effects of OSCC cells in the stimulation of osteolytic activity and bone invasion. METHODS: Direct co-culture was achieved by culturing OSCC (TCA8113) with a primary alveolar bone cell line. In the indirect co-culture, the supernatant of TCA8113 cells was collected to culture the alveolar bone cells. To assess the bone invasion properties, in vitro assays were performed. RESULTS: The proliferation of co-cultured cancer cells was significantly (p<0.05) higher in comparison to the monolayer control cells. However, the proliferation rates were not significantly different between direct and indirect co-cultured cells with indirect co-cultured cells proliferated slightly more than the direct co-cultured cells. Invasion and migration capacities of co-cultured OSCC and alveolar bone cells enhanced significantly (p<0.05) when compared to that of control monolayer counterparts. Most importantly, we noted that OSCC cells directly co-cultured with alveolar bone cells stimulated pronounced bone collagen destruction. In addition, stem cells and epithelialmesenchymal transition markers have shown significant changes in their expression in co-cultured cells. CONCLUSION: In conclusion, the findings of this study highlight the importance of the interaction of alveolar bone cells and OSCC cells in co-culture setting in the pathogenesis of bone invasion. This may help in the development of potential future biotherapies for bone invasion in OSCC.


Subject(s)
Alveolar Bone Loss/pathology , Biomarkers/metabolism , Carcinoma, Squamous Cell/pathology , Mouth Neoplasms/pathology , Osteoclasts/pathology , Alveolar Bone Loss/metabolism , Carcinoma, Squamous Cell/metabolism , Cell Movement , Cell Proliferation , Coculture Techniques , Epithelial-Mesenchymal Transition , Humans , Mouth Neoplasms/metabolism , Neoplasm Invasiveness , Osteoclasts/metabolism , Tumor Cells, Cultured
3.
Exp Cell Res ; 370(2): 245-253, 2018 09 15.
Article in English | MEDLINE | ID: mdl-29958837

ABSTRACT

OBJECTIVES: In this study, we aimed to investigate the expression pattern, clinicopathological significance and tumour suppressive properties of miR-15a in patients with colorectal carcinomas. METHODS: Tissue samples from 87 patients with primary colorectal carcinomas, 50 matched metastatic lymph node and 37 non-neoplastic colon (control) were prospectively recruited. The expression level of miR-15a was measured by quantitative real-time polymerase chain reaction. Restoration/overexpression of the miR-15a was achieved by exogenous transfection. Four colon cancer cell lines (SW480, CaCO2, SW48 and HCT116) and a non-cancer colon cell line (FHC) were also used for examining the miR-15a induced tumour suppression properties using various in-vitro and immunological assays. RESULTS: Downregulation of miR-15a was noted in ~ 62% of the colorectal carcinoma tissues and it was positively correlated with the presence of cancer recurrence in patients with colorectal carcinomas (p = 0.05). Also, these patients with low miR-15a expression showed relatively shorter survival time when compared to those with miR-15a overexpression. Following miR-15a exogenous overexpression, colon cancer cells showed reduced cell proliferation, low colony formation, less cell invasion properties and mitochondrial respiration when compared to control cells. In addition, BCL2 and SOX2 proteins showed a significant downregulation following miR-15a overexpression suggesting its regulatory role in cancer growth, apoptosis and stemness. CONCLUSION: This study has confirmed the tumour suppressor properties of miR-15a in colorectal cancers. Therefore, its modulation has potential implications in controlling various biological and pathogenic processes in colon carcinogenesis via targeting its downstream proteins such as BCL2 and SOX2.


Subject(s)
Colorectal Neoplasms/genetics , Gene Expression Regulation, Neoplastic/genetics , MicroRNAs/genetics , Proto-Oncogene Proteins c-bcl-2/genetics , SOXB1 Transcription Factors/genetics , Apoptosis/genetics , Carcinogenesis/genetics , Cell Line, Tumor , Cell Proliferation/genetics , Colonic Neoplasms/genetics , Colonic Neoplasms/pathology , Colorectal Neoplasms/pathology , Female , Genes, Tumor Suppressor , Humans , Male , MicroRNAs/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...